PhD, University of Bern
Head of Research & Development, InnoMedica Holding and Country Manager, InnoMedica Switzerland
Stéfan Halbherr has been working at InnoMedica Holding AG since 2013 as Head of Research & Development. He has experience in immunology and has been a scientific consultant for the project in the field of oncology from the very beginning. As Country Manager InnoMedica Schweiz AG, he is the driving force which advances the optimization of the product and his creative approach to research yields steady development progress. He is listed as the inventor in the new patent application for the drug against neurodegenerative diseases. After his Master's degree in Biochemistry and Immunology at the University of Bern, Stéfan received his PhD at the Institute of Virology and Immunoprophylaxis IVI from the University of Bern for his research on «Development of a high-quality vaccine against avian influenza».
